Summary
The global Urological Cancer Therapeutics Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Xofigo (radium Ra 223 dichloride)
Jevtana (cabazitaxel)
Inlyta (axitinib)
Votrient (pazopanib hydrochloride)
Sutent (sunitinib malate)
Zytiga (abiraterone acetate)
Xtandi (enzalutamide)
Opdivo (nivolumab)
Provenge (sipuleucel-T)
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Novartis
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Bristol-Myers Squibb
Abbott Laboratories
Celgene Corporation
Dendreon Corporation
Ferring Pharmaceuticals
GlaxoSmithKline plc
Indevus Pharmaceuticals Inc
Ipsen
Roche Healthcare
Sanofi S.A.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital
Medical Research Laboratory
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Interested in this report?
Get your sample now!
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Xofigo (radium Ra 223 dichloride)
1.2.1.2 Jevtana (cabazitaxel)
1.2.1.3 Inlyta (axitinib)
1.2.1.4 Votrient (pazopanib hydrochloride)
1.2.1.5 Sutent (sunitinib malate)
1.2.1.6 Zytiga (abiraterone acetate)
1.2.1.7 Xtandi (enzalutamide)
1.2.1.8 Opdivo (nivolumab)
1.2.1.9 Provenge (sipuleucel-T)
1.2.2 by Application
1.2.2.1 Hospital
1.2.2.2 Medical Research Laboratory
1.2.2.3 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Xofigo (radium Ra 223 dichloride) Market, 2013-2018
4.1.2 Jevtana (cabazitaxel) Market, 2013-2018
4.1.3 Inlyta (axitinib) Market, 2013-2018
4.1.4 Votrient (pazopanib hydrochloride) Market, 2013-2018
4.1.5 Sutent (sunitinib malate) Market, 2013-2018
4.1.6 Zytiga (abiraterone acetate) Market, 2013-2018
4.1.7 Xtandi (enzalutamide) Market, 2013-2018
4.1.8 Opdivo (nivolumab) Market, 2013-2018
4.1.9 Provenge (sipuleucel-T) Market, 2013-2018
4.2 Market Forecast
4.2.1 Xofigo (radium Ra 223 dichloride) Market Forecast, 2019-2024
4.2.2 Jevtana (cabazitaxel) Market Forecast, 2019-2024
4.2.3 Inlyta (axitinib) Market Forecast, 2019-2024
4.2.4 Votrient (pazopanib hydrochloride) Market Forecast, 2019-2024
4.2.5 Sutent (sunitinib malate) Market Forecast, 2019-2024
4.2.6 Zytiga (abiraterone acetate) Market Forecast, 2019-2024
4.2.7 Xtandi (enzalutamide) Market Forecast, 2019-2024
4.2.8 Opdivo (nivolumab) Market Forecast, 2019-2024
4.2.9 Provenge (sipuleucel-T) Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Market, 2013-2018
5.1.2 Medical Research Laboratory Market, 2013-2018
5.1.3 Others Market, 2013-2018
5.2 Market Forecast
5.2.1 Hospital Market Forecast, 2019-2024
5.2.2 Medical Research Laboratory Market Forecast, 2019-2024
5.2.3 Others Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Novartis
8.2 Pfizer
8.3 Johnson & Johnson
8.4 AstraZeneca
8.5 Astellas
8.6 Bristol-Myers Squibb
8.7 Abbott Laboratories
8.8 Celgene Corporation
8.9 Dendreon Corporation
8.10 Ferring Pharmaceuticals
8.11 GlaxoSmithKline plc
8.12 Indevus Pharmaceuticals Inc
8.13 Ipsen
8.14 Roche Healthcare
8.15 Sanofi S.A.
9 Conclusion
Table Product Specifications of Urological Cancer Therapeutics Drugs
Table Products Segment of Urological Cancer Therapeutics Drugs
Table Xofigo (radium Ra 223 dichloride) Overview
Table Jevtana (cabazitaxel) Overview
Table Inlyta (axitinib) Overview
Table Votrient (pazopanib hydrochloride) Overview
Table Sutent (sunitinib malate) Overview
Table Zytiga (abiraterone acetate) Overview
Table Xtandi (enzalutamide) Overview
Table Opdivo (nivolumab) Overview
Table Provenge (sipuleucel-T) Overview
Table Global Urological Cancer Therapeutics Drugs Market by Type, 2011-2022 (USD Million)
Table Application Segment of Urological Cancer Therapeutics Drugs
Table Hospital Overview
Table Medical Research Laboratory Overview
Table Others Overview
Table Global Urological Cancer Therapeutics Drugs Market by Application, 2011-2022 (USD Million)
Table Global Urological Cancer Therapeutics Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Urological Cancer Therapeutics Drugs
Table Market Dynamics
Table Policy of Urological Cancer Therapeutics Drugs
Table GDP of Major Countries
Table Xofigo (radium Ra 223 dichloride) CAGR by Revenue and Volume, 2012-2018
Table Jevtana (cabazitaxel) CAGR by Revenue and Volume, 2012-2018
Table Inlyta (axitinib) CAGR by Revenue and Volume, 2012-2018
Table Votrient (pazopanib hydrochloride) CAGR by Revenue and Volume, 2012-2018
Table Sutent (sunitinib malate) CAGR by Revenue and Volume, 2012-2018
Table Zytiga (abiraterone acetate) CAGR by Revenue and Volume, 2012-2018
Table Xtandi (enzalutamide) CAGR by Revenue and Volume, 2012-2018
Table Opdivo (nivolumab) CAGR by Revenue and Volume, 2012-2018
Table Provenge (sipuleucel-T) CAGR by Revenue and Volume, 2012-2018
Table Xofigo (radium Ra 223 dichloride) CAGR by Revenue and Volume, 2012-2024
Table Jevtana (cabazitaxel) CAGR by Revenue and Volume, 2012-2024
Table Inlyta (axitinib) CAGR by Revenue and Volume, 2012-2024
Table Votrient (pazopanib hydrochloride) CAGR by Revenue and Volume, 2012-2024
Table Sutent (sunitinib malate) CAGR by Revenue and Volume, 2012-2024
Table Zytiga (abiraterone acetate) CAGR by Revenue and Volume, 2012-2024
Table Xtandi (enzalutamide) CAGR by Revenue and Volume, 2012-2024
Table Opdivo (nivolumab) CAGR by Revenue and Volume, 2012-2024
Table Provenge (sipuleucel-T) CAGR by Revenue and Volume, 2012-2024
Table Hospital CAGR by Revenue and Volume, 2012-2018
Table Medical Research Laboratory CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Global Urological Cancer Therapeutics Drugs Market by Vendors, 2012-2018 (USD Million)
Table Global Urological Cancer Therapeutics Drugs Market by Vendors, 2012-2018 (in Volume)
Table Global Urological Cancer Therapeutics Drugs Market Share by Vendors, 2012-2018 (USD Million)
Table Global Urological Cancer Therapeutics Drugs Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Novartis Profile List
Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Profile List
Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Astellas Profile List
Table Microecological Modulator Operating Data of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbott Laboratories Profile List
Table Microecological Modulator Operating Data of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corporation Profile List
Table Microecological Modulator Operating Data of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dendreon Corporation Profile List
Table Microecological Modulator Operating Data of Dendreon Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ferring Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Ferring Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Indevus Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of Indevus Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ipsen Profile List
Table Microecological Modulator Operating Data of Ipsen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Healthcare Profile List
Table Microecological Modulator Operating Data of Roche Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. Profile List
Table Microecological Modulator Operating Data of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Figure Urological Cancer Therapeutics Drugs Picture
Figure Industry Chain Structure of Urological Cancer Therapeutics Drugs
Figure SWOT of Urological Cancer Therapeutics Drugs
Figure Xofigo (radium Ra 223 dichloride) Market Size and Growth, 2012-2018 (USD Million)
Figure Xofigo (radium Ra 223 dichloride) Market Size and Growth, 2012-2018 (in Volume)
Figure Jevtana (cabazitaxel) Market Size and Growth, 2012-2018 (USD Million)
Figure Jevtana (cabazitaxel) Market Size and Growth, 2012-2018 (in Volume)
Figure Inlyta (axitinib) Market Size and Growth, 2012-2018 (USD Million)
Figure Inlyta (axitinib) Market Size and Growth, 2012-2018 (in Volume)
Figure Votrient (pazopanib hydrochloride) Market Size and Growth, 2012-2018 (USD Million)
Figure Votrient (pazopanib hydrochloride) Market Size and Growth, 2012-2018 (in Volume)
Figure Sutent (sunitinib malate) Market Size and Growth, 2012-2018 (USD Million)
Figure Sutent (sunitinib malate) Market Size and Growth, 2012-2018 (in Volume)
Figure Zytiga (abiraterone acetate) Market Size and Growth, 2012-2018 (USD Million)
Figure Zytiga (abiraterone acetate) Market Size and Growth, 2012-2018 (in Volume)
Figure Xtandi (enzalutamide) Market Size and Growth, 2012-2018 (USD Million)
Figure Xtandi (enzalutamide) Market Size and Growth, 2012-2018 (in Volume)
Figure Opdivo (nivolumab) Market Size and Growth, 2012-2018 (USD Million)
Figure Opdivo (nivolumab) Market Size and Growth, 2012-2018 (in Volume)
Figure Provenge (sipuleucel-T) Market Size and Growth, 2012-2018 (USD Million)
Figure Provenge (sipuleucel-T) Market Size and Growth, 2012-2018 (in Volume)
Figure Xofigo (radium Ra 223 dichloride) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Xofigo (radium Ra 223 dichloride) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Jevtana (cabazitaxel) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Jevtana (cabazitaxel) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Inlyta (axitinib) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Inlyta (axitinib) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Votrient (pazopanib hydrochloride) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Votrient (pazopanib hydrochloride) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Sutent (sunitinib malate) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Sutent (sunitinib malate) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Zytiga (abiraterone acetate) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Zytiga (abiraterone acetate) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Xtandi (enzalutamide) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Xtandi (enzalutamide) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Opdivo (nivolumab) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Opdivo (nivolumab) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Provenge (sipuleucel-T) Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Provenge (sipuleucel-T) Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Hospital Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Medical Research Laboratory Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Urological Cancer Therapeutics Drugs Market Concentration by Region
Figure Marketing Channels Overview
